JPS62224259A - Nourishing meal - Google Patents

Nourishing meal

Info

Publication number
JPS62224259A
JPS62224259A JP61065901A JP6590186A JPS62224259A JP S62224259 A JPS62224259 A JP S62224259A JP 61065901 A JP61065901 A JP 61065901A JP 6590186 A JP6590186 A JP 6590186A JP S62224259 A JPS62224259 A JP S62224259A
Authority
JP
Japan
Prior art keywords
albumin
protein
nutritional food
meal
nutritional
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP61065901A
Other languages
Japanese (ja)
Inventor
Hiromoto Asai
浅井 宏基
Tadashi Kurachi
倉知 忠史
Masatsune Kurono
昌庸 黒野
Kazumasa Nakano
中野 万正
Fumiichiro Yasui
文一郎 安井
Noboru Kuboyama
久保山 登
Kiichi Sawai
喜一 澤井
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanwa Kagaku Kenkyusho Co Ltd
Original Assignee
Sanwa Kagaku Kenkyusho Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanwa Kagaku Kenkyusho Co Ltd filed Critical Sanwa Kagaku Kenkyusho Co Ltd
Priority to JP61065901A priority Critical patent/JPS62224259A/en
Publication of JPS62224259A publication Critical patent/JPS62224259A/en
Pending legal-status Critical Current

Links

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

PURPOSE:To obtain a nourishing meal, readily and orally ingestible, having good digestibility and absorbability, high nutritive value and improved patalability and effective for improving hypoproteinemia and hypoalbuminemia. CONSTITUTION:A nourishing meal containing protein consisting essentially of albumin derived from animals, glucide and nucleic acid. The weight proportion thereof in the nourshing meal is preferably 10-90% protein, 1-90% glucide and 0.5-10% nucleic acid. At least one of one milk albumin and egg albumin may be used as the albumin derived from animals. At least one of animal and vegetable proteins other than such albumins may be contained as the protein in the meal.

Description

【発明の詳細な説明】 (産業上の利用分野) 本発明は栄養食に係り、殊に各種の疾患例えば肝障害(
肝硬変、慢性肝炎等)、腎障害(ネフローゼ、透析患者
等)、消化管障害(消化器潰瘍、吸収不良症候群等)、
悪性腫瘍等に起因して栄養状態不良となり、その結果低
蛋白血症や低アルブミン血症を呈している患者に与える
のに極めて好適な栄養食に係る。
DETAILED DESCRIPTION OF THE INVENTION (Industrial Application Field) The present invention relates to nutritional foods, and particularly to nutritional foods for various diseases such as liver disorders (
liver cirrhosis, chronic hepatitis, etc.), renal disorders (nephrosis, dialysis patients, etc.), gastrointestinal disorders (gastrointestinal ulcers, malabsorption syndrome, etc.),
The present invention relates to a nutritional food that is extremely suitable to be given to patients who suffer from poor nutritional status due to malignant tumors or the like, and as a result exhibit hypoproteinemia or hypoalbuminemia.

本発明による栄養食は、上記のような患者用としてのみ
ならず、一般の健康人や成長期にある乳児、児童に対し
栄養補給及び筋肉強化を目的として与える場合にも好適
である。
The nutritional food according to the present invention is suitable not only for patients as described above, but also for general healthy people, growing infants, and children for the purpose of nutritional supplementation and muscle strengthening.

(従来の技術及びその問題点) 従来、低蛋白血症や低アルブミン血症を改善するために
、非経口的方策としては静脈栄養又は経腸栄養による蛋
白及びアミノ酸の補給が行われており、又経口的方策と
しては高蛋白食又は蛋白補助剤の摂取が行われている。
(Prior art and its problems) Conventionally, in order to improve hypoproteinemia and hypoalbuminemia, parenteral measures include supplementation of proteins and amino acids through parenteral nutrition or enteral nutrition. Oral strategies include ingestion of high protein foods or protein supplements.

患者が経口摂取不能の場合に、静脈栄養は有用であるが
、手技が繁雑であり、経済的な負担も大きく、又感染症
等の副作用発生の心配がある。経腸栄養による蛋白及び
アミノ酸の補給は感染症の心配がなく、経済的にも負担
が少ないが、長期にわたる経管栄養投与は患者にとって
苦痛であり、又下痢等の副作用を生じ易い。
Parenteral nutrition is useful when a patient is unable to take oral intake, but it is a complicated procedure, imposes a large economic burden, and there is a concern that side effects such as infection may occur. Supplementation of protein and amino acids through enteral nutrition is free from infectious diseases and is less of an economic burden; however, long-term administration of enteral nutrition is painful for patients and tends to cause side effects such as diarrhea.

これらの非経口摂取と比較する場合に、経口摂取による
補給は容易であり、生理的に優れ、経済的な負担も少な
く、従って消化能力を有している患者に関しては有用性
が最も高−い。しかしながら、蛋白及びアミノ酸の経口
補給用として現在供されている高蛋白食乃至蛋白補助剤
は大豆蛋白を主体としたものが多く、消化吸収性、栄養
価及び嗜好性の面を考慮に入れる場合に、低蛋白血症や
低アルブミン血症の改善に有効であり且つ適切な経口栄
養食は存在しないのが実情である。
When compared with these parenteral supplements, oral supplementation is easy, physiologically superior, and has less economical burden, and is therefore most useful for patients who have the ability to digest it. . However, many of the high-protein foods and protein supplements currently available for oral supplementation of protein and amino acids are mainly based on soybean protein. The reality is that there is no oral nutritional food that is effective and appropriate for improving hypoproteinemia and hypoalbuminemia.

(発明の目的) 従って、本発明の目的は経口摂取が容易であって、消化
吸収が良好であり、栄養価が高く、しかも嗜好性にも優
れており、その結果低蛋白血症や低アルブミン血症の改
善に有効な栄養食を提供することである。
(Objective of the Invention) Therefore, the object of the present invention is to provide a product that is easy to take orally, has good digestion and absorption, has high nutritional value, and has excellent palatability, resulting in hypoproteinemia and low albuminemia. The aim is to provide nutritional food that is effective in improving blood pressure.

(目的を達成するための手段及び作用)本発明によれば
、上記の目的は、動物由来のアルブミンを主体とする蛋
白質と、糖質と、核酸とを含有している栄養食により達
成される。
(Means and Effects for Achieving the Object) According to the present invention, the above object is achieved by a nutritional food containing protein, mainly albumin derived from an animal, carbohydrates, and nucleic acids. .

本発明による栄養食における量割合に関しては、上記蛋
白質を10−90%、上記糖質を 1−90%、また上
記核酸を0.5−10% とするのが適当である。
Regarding the proportions in the nutritional food according to the present invention, it is appropriate that the protein be 10-90%, the carbohydrate be 1-90%, and the nucleic acid be 0.5-10%.

動物由来のアルブミンとしては乳アルブミン及び卵アル
ブミンの少なくとも一種であることできる。蛋白質とし
てこれらのアルブミン以外に動物性及び植物性蛋白の少
なくとも一種を含有していることができ、この場合に動
物性蛋白としてはカゼイン、ゼラチン及び卵白等を挙げ
ることができ、又植物性蛋白としては大豆蛋白及び小麦
蛋白等を挙げることができる。上記の動物性アルブミン
はそのアミノ酸組成において制限アミノ酸が存在しない
ので蛋白質として良質であり且つ肝臓で生合成されるア
ルブミンとほぼ同一の組成を有している。尚、乳アルブ
ミンはシスチン及びトリプトファン含量が高く且つアミ
ノ酸組成も良好であり、一方卵アルブミンも他の蛋白と
比較する場合に含量アミノ酸、殊にメチオニン含量が高
い点において優れている。
The animal-derived albumin can be at least one of milk albumin and egg albumin. In addition to these albumins, the protein may contain at least one of animal and vegetable proteins, and in this case, the animal proteins include casein, gelatin, egg white, etc. Examples include soybean protein and wheat protein. The above-mentioned animal albumin has no limiting amino acids in its amino acid composition, so it is of high quality as a protein and has almost the same composition as albumin biosynthesized in the liver. Milk albumin has a high cystine and tryptophan content and a good amino acid composition, while egg albumin is also superior to other proteins in that it has a high amino acid content, especially methionine content.

従って、本発明による栄養食は患者に投与摂取される場
合に低蛋白血症や低アルブミン血症を有効に改善するこ
とができる。
Therefore, the nutritional food according to the present invention can effectively improve hypoproteinemia and hypoalbuminemia when administered to a patient.

糖質としてはデンプン、デキストリン、マルトース、ソ
ルビット、果糖、ブドウ糖及び庶糖等を挙げることがで
きる。糖質の添加は糖質自体の補給のためのみならず、
栄養食原料の造粒性を良好ならしめ、更には造粒により
形成された粉末の溶解性を向上させる効果を有している
Examples of carbohydrates include starch, dextrin, maltose, sorbitol, fructose, glucose, and sucrose. The addition of carbohydrates is not only for the purpose of replenishing the carbohydrates themselves;
It has the effect of improving the granulation properties of nutritional food raw materials and further improving the solubility of the powder formed by granulation.

核酸は生体内での蛋白の合成促進及び蛋白質代謝の元通
をもたらすために添加される。
Nucleic acids are added to promote protein synthesis and normalize protein metabolism in vivo.

本栄養食を水、牛乳、ジュース、紅茶等に溶解させる場
合に溶解性を良好になす目的で、必要であれば乳化剤を
添加することができ、この乳化剤としてはポリグリセリ
ン脂肪酸エステルを用いるのが好ましい。
When dissolving this nutritional food in water, milk, juice, black tea, etc., an emulsifier can be added if necessary to improve solubility. As the emulsifier, it is recommended to use polyglycerin fatty acid ester. preferable.

尚、本発明による栄養食には、上記の諸成分以外にも必
要に応じて各種の脂質、ビタミン類、ミネラル類等を添
加配合することができる。
In addition to the above-mentioned components, various lipids, vitamins, minerals, etc. may be added to the nutritional food according to the present invention as required.

(発明の効果) 本発明による栄養食は、栄養不良の低蛋白血症患者や、
低アルブミン血症を伴う肝硬変、慢性肝炎、ネフローゼ
、大腸性潰瘍炎患者に経口摂取させる場合に栄養改善効
果及び病状の改善効果をもたらす。即ち、血清総蛋白及
びアルブミン値の上昇、体重の増加並びに浮腫の消失が
もたらされるのである。
(Effects of the Invention) The nutritional food according to the present invention can be used for malnourished hypoproteinemic patients,
When orally ingested by patients with cirrhosis, chronic hepatitis, nephrosis, and ulcerative colitis associated with hypoalbuminemia, it has nutritional and disease-improving effects. That is, an increase in serum total protein and albumin levels, an increase in body weight, and a disappearance of edema are brought about.

(製造例等) 次に、本発明による栄養食の製造例、経口摂取させた場
合の動物及び臨床試験例に関連して本発明を更に詳細に
説明する。
(Manufacturing Examples, etc.) Next, the present invention will be described in more detail with reference to manufacturing examples of nutritional foods according to the present invention, animals in the case of oral ingestion, and clinical test examples.

11匠−り 乳アルブミン         69.0 (%)卵ア
ルブミン         17.5ゼラチン    
        7.5核酸            
 1.0デキストリン          2.5ソル
ビツト          2.0ポリグリセリン脂肪
酸エステル 0.5上記の諸成分の内で乳アルブミン、
ゼラチン、核酸及びデキストリンを上記の割合で先ず混
合する。この混合物に、ソルビットを水に溶解させたも
のをスプレーして造粒し、次いでポリグリセリン脂肪酸
エステルを水に溶解させたものをスプレーして造粒する
ことにより粉末状の栄養食を製造した。
11 Takumi Milk Albumin 69.0 (%) Egg Albumin 17.5 Gelatin
7.5 Nucleic acids
1.0 Dextrin 2.5 Sorbit 2.0 Polyglycerin fatty acid ester 0.5 Among the above ingredients, milk albumin,
Gelatin, nucleic acid and dextrin are first mixed in the above proportions. This mixture was sprayed with sorbitol dissolved in water and granulated, and then polyglycerol fatty acid ester dissolved in water was sprayed and granulated to produce a powdered nutritional food.

この粉末状栄養食は水、牛乳、ジュース、コーヒー、紅
茶等に溶解させて飲用に供することができ、又成形して
菓子類となすための原料とすることができる。
This powdered nutritional food can be dissolved in water, milk, juice, coffee, tea, etc. for drinking, or can be molded and used as a raw material for confectionery.

製造例 2 乳アルブミン          3.5(%)卵アル
ブミン          0.8ゼラチン     
       0.4核酸             
 0.05デキストリン          0.15
ソルビツト           0.1乳脂肪   
          2.0ポリグリセリン脂肪酸エス
テル  0.05バニラフレーバー        0
.25水                     
 92,7乳アルブミン3500g、卵アルブミン80
0g 、ゼラチン400g 、核酸50g、デキストリ
ン150g及びツルピッl−+00Jtを95にgの水
に溶解させた。
Production example 2 Milk albumin 3.5 (%) Egg albumin 0.8 Gelatin
0.4 nucleic acid
0.05 Dextrin 0.15
Sorbittu 0.1 milk fat
2.0 Polyglycerin fatty acid ester 0.05 Vanilla flavor 0
.. 25 water
92.7 Milk albumin 3500g, egg albumin 80
0 g of gelatin, 400 g of gelatin, 50 g of nucleic acid, 150 g of dextrin, and Tsurupi l-+00Jt were dissolved in 95 g of water.

次いでポリグリセリン脂肪酸エステル50g、乳脂肪2
000g  及びバニラフレーバー250gを上記の溶
液に添加し、配合材料を均一に分散させた後に乳化させ
る。
Next, 50g of polyglycerin fatty acid ester, 2g of milk fat
000g and 250g of vanilla flavor are added to the above solution, and the ingredients are uniformly dispersed and then emulsified.

この乳化液を滅菌処理しく145°C13秒間)、均質
機で処理することにより液状の栄養食約100Kg  
を得た。この液状栄養食を室温下に24時間放置したが
、離水及び油分溝は何等認められず乳1ヒ安定性の良好
なことが判明した。
This emulsion was sterilized at 145°C for 13 seconds) and processed in a homogenizer to produce approximately 100 kg of liquid nutritional food.
I got it. This liquid nutritional food was left at room temperature for 24 hours, but no syneresis or oil grooves were observed, indicating good milk stability.

糺り漣−1 製造例1により得た粉末状栄養食10g  と砂糖15
gとを60m1  の水に溶解させた。一方溶きほぐし
た全卵30g  を上記の溶液に添加混合させた。この
混合物を型に注入し、弱火で15−20分間蒸煮した。
Tadarisen-1 10g of powdered nutritional food obtained according to Production Example 1 and 15g of sugar
g was dissolved in 60 ml of water. On the other hand, 30 g of beaten whole eggs were added to the above solution and mixed. This mixture was poured into molds and steamed on low heat for 15-20 minutes.

次いで、この蒸煮物を器に取り出し、カラメルソースを
かけてプリン菓子とした。
Next, this steamed product was taken out into a bowl and caramel sauce was poured over it to make a pudding confectionery.

製造例 4 サラダ油15g  と、溶きほぐした全卵10gと、°
砂糖legとを攪拌し、これに、製造例1で得た粉末状
栄養食10g  及び小麦粉25g  を添加して充分
に混合する。この混合物を絞出し袋に入れて適当な大き
さに絞出し、天火で焼成してクツキーを得た。
Production example 4 15g of salad oil, 10g of beaten whole egg, °
10 g of the powdered nutritional food obtained in Production Example 1 and 25 g of wheat flour were added to the sugar and mixed thoroughly. This mixture was put into a piping bag, squeezed out to an appropriate size, and baked in the oven to obtain kutski.

摂JU成】」生−」−(動物試験) 体重50g  前後であって3 退会のSle:SD系
雌雄性ラット市販の粉末飼料CA−1(日本フレア製)
と水とを自由摂取させて6 日間予備飼育した。
(Animal test) Body weight is around 50 g and 3 Sle of withdrawal: SD male and female rats commercially available powdered feed CA-1 (manufactured by Nippon Flare)
The animals were preliminarily reared for 6 days with free access to food and water.

6日間の馴化の後、カゼイン含量Ozの精製飼料を3 
週間自由摂取させることにより低蛋白血症ラットとなし
た。この低蛋白血症ラットの作製後、任意に、1群lO
匹からなる2つの試験群(i 及びII)  を作製し
た。
After 6 days of acclimatization, 3 oz of purified feed with a casein content of 3 oz.
The rats were made hypoproteinemic by giving them ad libitum for weeks. After generation of this hypoproteinemic rat, optionally one group 10
Two test groups (i and II) consisting of animals were created.

被験物質としての栄養食(製造例1)を、又対照物質と
しての大豆蛋白を、カゼイン含量lO%となるように配
合して、それぞれ被験飼料及び対照飼料を調製した。
A test feed and a control feed were prepared by blending a nutritional food (Production Example 1) as a test substance and soybean protein as a control substance so that the casein content was 10%.

第1群には被験飼料を、又第1I群には対照飼料をそれ
ぞれ1Sleg  宛3 週間の試験期間にわたり経口
摂取させた。
The test feed was orally ingested in Group 1 and the control feed in Group 1I for 1 Sleg each over a 3 week test period.

試験期間中に体重並びに血清中の総蛋白量及びアルブミ
ン量を測定してこれらの変化を調べた結果は第1−3 
 図のグラフに示される通りであって、第1I群(対照
飼料供与群)と比較して第1群(被験飼料供与群)に関
し体重、血清中の総蛋白量及びアルブミン量が有意に上
昇すること及び低蛋白血症の改善されることが判明した
The results of measuring body weight, serum total protein amount, and albumin amount during the test period and investigating these changes are shown in Sections 1-3.
As shown in the graph in the figure, the body weight, total protein amount, and albumin amount in serum are significantly increased in Group 1 (test feed group) compared to Group 1I (control feed group). It was also found that hypoproteinemia was improved.

4L隨1匠−と(臨床試験) a)低アルブミン直症を伴う非代償性肝硬変患者〈男性
、51  歳)に、製造例1による栄養食を1日3回(
20g/日)肝臓食に上乗せして投与摂取させた。
(Clinical trial) a) A patient (male, 51 years old) with decompensated liver cirrhosis with direct hypoalbumin was given the nutritional food according to Production Example 1 three times a day (
(20 g/day) was added to the liver meal.

この栄養食の投与前及び投与後に肝機能検査を適宜実施
した結果は、後記の表1に示される通りであった。この
表から、血清中の総蛋白量及びアルブミン量が栄養食の
投与から約1ケ月後に上昇し始めることか判明し、又コ
リンエステラーゼにも上昇傾向が認められ、従って肝で
蛋白やコリンエステラーゼの産生が几進していることが
判明した。尚、上記3種の検査値以外の検査値には有意
の変化が認められなかった。
Liver function tests were conducted as appropriate before and after administration of this nutritional food, and the results were as shown in Table 1 below. From this table, it is clear that the total protein and albumin levels in the serum begin to rise about one month after the administration of nutritional food, and that cholinesterase also tends to rise, so that the production of protein and cholinesterase in the liver is reduced. It turned out that it was progressing. Note that no significant changes were observed in test values other than the above three test values.

栄養食の投与から1−2ケ月で栄養状態、病状共に良化
し、又下痢等の副作用は何等認められなかった。
One to two months after the administration of the nutritional food, both the nutritional status and the medical condition improved, and no side effects such as diarrhea were observed.

b)栄養状!ぶの良くない大腸炎患者(男性、17歳)
に、製造PA1による栄養食を水、ジュース等に混入さ
せて1日3回(20g/日)投与摂取させた。尚、食事
としては全粥食を摂取させた。
b) Nutritional status! A patient with colitis who is not feeling well (male, 17 years old)
The nutritional food manufactured by PA1 was mixed with water, juice, etc., and administered three times a day (20 g/day). In addition, the animals were fed a whole porridge diet.

上記の患者は従来ニレメンタルダイエツトを摂取してい
たが、下痢が多いために栄養状態の良化をもたらし得な
かったのであるが、ニレメンタルダイエツト食を上記の
通りの栄養食と全粥食に代えた結果は後記の表2に肝機
能検査値の推移が示されている通りであって血清中の総
蛋白量及びアルブミン量が増加し、体重も増加して栄養
状態が良化し、病状も徐々に回復した。
The patient mentioned above had previously been taking an Elemental diet, but due to frequent diarrhea, it was not possible to improve his nutritional status. The results of this change are as shown in Table 2 below, which shows the changes in liver function test values; total protein and albumin levels in serum increased, body weight increased, nutritional status improved, and disease symptoms also improved. He gradually recovered.

【図面の簡単な説明】[Brief explanation of drawings]

第1図は本発明による栄養食を含有する被験飼料及び大
豆蛋白を含有する対照飼料を低蛋白血症ラッ1へに摂取
させて体重変化の推移を調べた結果を示すグラフ、第2
図は第1図と同様の、但し血清中の総蛋白量変化の推移
を調べた結果を示すグラフ、第3図は第1図と同様の、
但し血清中のアルブミン量変化の推移を調べた結果を示
すグラフである。 特許出願人  株式会社 三和化学研究所第1図 、経過時間C尾) 一:穆、胛騨慴与群 −:灯胴桐竹我与群
Figure 1 is a graph showing the results of examining changes in body weight of hypoproteinemic rats 1 after ingesting test feed containing the nutritional food according to the present invention and control feed containing soybean protein;
The figure is the same as Figure 1, except that it is a graph showing the results of examining changes in the total protein amount in serum, and Figure 3 is the same as Figure 1.
However, this is a graph showing the results of examining changes in the amount of albumin in serum. Patent applicant: Sanwa Kagaku Kenkyusho Co., Ltd. Figure 1, elapsed time C tail) 1: Mu, Chikugayo group -: Todo Kiri Chikugayo group

Claims (4)

【特許請求の範囲】[Claims] (1)動物由来のアルブミンを主体とする蛋白質と、糖
質と、核酸とを含有していることを特徴とする、栄養食
(1) A nutritional food characterized by containing protein, mainly animal-derived albumin, carbohydrates, and nucleic acids.
(2)量割合において蛋白質が10−90%であり、糖
質が1−90%であり、核酸が0.5−10%であるこ
とを特徴とする、特許請求の範囲第1項に記載の栄養食
(2) Claim 1, characterized in that the amount ratio is 10-90% protein, 1-90% carbohydrate, and 0.5-10% nucleic acid. nutritional food.
(3)動物由来のアルブミンが乳アルブミン及び卵アル
ブミンの少なくとも一種であることを特徴とする、特許
請求の範囲第1項に記載の栄養食。
(3) The nutritional food according to claim 1, wherein the animal-derived albumin is at least one of milk albumin and egg albumin.
(4)蛋白質がアルブミン以外の成分として動物性蛋白
及び植物性蛋白の少なくとも一種を含有していることを
特徴とする、特許請求の範囲第1項に記載の栄養食。
(4) The nutritional food according to claim 1, wherein the protein contains at least one of animal protein and vegetable protein as a component other than albumin.
JP61065901A 1986-03-26 1986-03-26 Nourishing meal Pending JPS62224259A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP61065901A JPS62224259A (en) 1986-03-26 1986-03-26 Nourishing meal

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61065901A JPS62224259A (en) 1986-03-26 1986-03-26 Nourishing meal

Publications (1)

Publication Number Publication Date
JPS62224259A true JPS62224259A (en) 1987-10-02

Family

ID=13300328

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61065901A Pending JPS62224259A (en) 1986-03-26 1986-03-26 Nourishing meal

Country Status (1)

Country Link
JP (1) JPS62224259A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02145170A (en) * 1988-11-29 1990-06-04 Nippon Oil & Fats Co Ltd Liquid protein assistant food
WO1991015127A1 (en) * 1990-04-06 1991-10-17 Otsuka Pharmaceutical Co., Ltd. High-protein high-viscosity alimentary food composition
WO2000043035A1 (en) * 1999-01-19 2000-07-27 Nissho Corporation Amino acid-containing albumin preparations
JP2002241283A (en) * 2001-02-13 2002-08-28 Nippon Zoki Pharmaceut Co Ltd Hypoalbuminemia-improving medicine
JP2019083814A (en) * 2017-11-02 2019-06-06 マルハニチロ株式会社 Food composition for preventing and/or improving liver dysfunction or hepatic dysfunction, containing dna as an active ingredient

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60120962A (en) * 1983-12-05 1985-06-28 Idemitsu Kosan Co Ltd Food and drink enriched with nucleic acid
JPS60203172A (en) * 1984-03-29 1985-10-14 Sanwa Kagaku Kenkyusho:Kk Nutrient food administered orally or through tract

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60120962A (en) * 1983-12-05 1985-06-28 Idemitsu Kosan Co Ltd Food and drink enriched with nucleic acid
JPS60203172A (en) * 1984-03-29 1985-10-14 Sanwa Kagaku Kenkyusho:Kk Nutrient food administered orally or through tract

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02145170A (en) * 1988-11-29 1990-06-04 Nippon Oil & Fats Co Ltd Liquid protein assistant food
JPH0560899B2 (en) * 1988-11-29 1993-09-03 Nippon Oils & Fats Co Ltd
WO1991015127A1 (en) * 1990-04-06 1991-10-17 Otsuka Pharmaceutical Co., Ltd. High-protein high-viscosity alimentary food composition
WO2000043035A1 (en) * 1999-01-19 2000-07-27 Nissho Corporation Amino acid-containing albumin preparations
JP2002241283A (en) * 2001-02-13 2002-08-28 Nippon Zoki Pharmaceut Co Ltd Hypoalbuminemia-improving medicine
JP4711523B2 (en) * 2001-02-13 2011-06-29 日本臓器製薬株式会社 Hypoalbuminemia improving agent
JP2019083814A (en) * 2017-11-02 2019-06-06 マルハニチロ株式会社 Food composition for preventing and/or improving liver dysfunction or hepatic dysfunction, containing dna as an active ingredient

Similar Documents

Publication Publication Date Title
US4112123A (en) Nutritionally balanced single food composition and method of production
JPS63502558A (en) Sweet confectionery products and their manufacturing methods
KR960003888B1 (en) Liquid nutritional formula for glucose intolerance
JP2003533438A (en) Carbohydrate formulations for enhancing immune response (prebiotic adjuvants)
CA2261708A1 (en) Composition of pyruvate and protein and method for increasing protein concentration in a mammal
KR20070112811A (en) Amino acid composition for improving glucose tolerance
JPS6236645B2 (en)
WO1998008402A1 (en) Nutritional formula for phenylketonuria patients
US20030124198A1 (en) Nutritional or therapeutic supplement and method
WO1986007262A1 (en) High caloric, high fat dietary formula
JP3907098B2 (en) Nutritional drink or jelly
US5849335A (en) Composition and method for providing glutamine
JPH0347829B2 (en)
JP3544493B2 (en) Nutrition composition for infants
JPH0394655A (en) Nutrient feeding composition
KR0160272B1 (en) High-protein, high-viscosity alimentary food composition
JPH11263733A (en) Lipid metabolism improver
ES2219928T5 (en) ACCELERATION METHOD OF THE DIGESTION SPEED OF A PROTEIN AND ITS EMPLOYMENT.
JPS62224259A (en) Nourishing meal
JPS6322525A (en) Hematinic
EP0665012B1 (en) Antiallergy agent and nutritional composition containing glutamine
US6797290B2 (en) Compositions for appetite control and related methods
JPH08259461A (en) Lipometabolism improver
JP3285959B2 (en) Liquid preparation nutritional food for long-term medical care patients
AU2002325007A1 (en) Compositions for appetite control and related methods